Adherium (ASX:ADR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Adherium (ASX:ADR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appointment of Chief Financial Officer
AUD$700,000 Short-Term Loan Facility from Barvest Ventures
Appendix 4G & Corporate Governance Statement
Annual Report to shareholders
Adherium grows FY2026 revenue 157% but auditors flag material going concern uncertainty
Adherium Consolidates Funding into A$4.67M Term Loan
Preliminary Final Report
Adherium reports 157% revenue growth but increased net loss of $14.16 million for FY2026
Change of Company Secretary
Adherium enters into additional $1M short-term loan facility
Adherium secures additional AUD 1 million loan from major shareholder Trudell for working capital
Ceasing to be a substantial holder
Adherium Announces CEO Transition
Adherium CEO Dawn Bitz steps down; John Perry appointed Interim CEO
Quarterly Activities/Appendix 4C Cash Flow Report
Adherium reports record RPM revenue growth and strong clinical validation, advancing value-based care strategy
Adherium - Investor Update
Adherium reports strong RPM revenue growth, clinical evidence, and advancing value-based care contracts